|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| C07D 487/04 | |||
| A61K 31/437 | |||
| A61K 31/519 | |||
| A61P 13/12 | |||
| A61P 9/10 |
| (11) | Patento numeris | 3271357 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16715122.4 |
| Europos patento paraiškos padavimo data | 2016-03-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-01-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-11-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/JP2016/059782 |
| Data | 2016-03-17 |
| (87) | Numeris | WO 2016/148306 |
| Data | 2016-09-22 |
| (30) | Numeris | Data | Šalis |
| 201504565 | 2015-03-18 | GB |
| (72) |
AHMED, Saleh, GB
BARKER, Gregory, GB
CANNING, Hannah, GB
DAVENPORT, Richard, GB
HARRISON, David, GB
JENKINS, Kerry, GB
LIVERMORE, David, GB
WRIGHT, Susanne, GB
KINSELLA, Natasha, GB
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045,
JP
|
| (54) | FUSED BICYCLIC HETEROARYL DERIVATIVES HAVING ACTIVITY AS PHD INHIBITORS |
| FUSED BICYCLIC HETEROARYL DERIVATIVES HAVING ACTIVITY AS PHD INHIBITORS |